| Literature DB >> 32656230 |
Dimitrios Rigopoulos1, Anna Stathopoulou1, Stamatios Gregoriou1.
Abstract
Nail psoriasis (PsO) is a disorder with profound impact on patients' quality of life. Several challenges and unmet needs remain in the treatment of nail PsO. Introduction of biologics and small molecules in the treatment of nail PsO has allowed for rapid control of the disease and high efficacy. The aim of this review was to present the published studies on nail PsO therapy with biologics and small molecules and illuminate the results in the studies where the design and outcome evaluation had nail PsO in the forefront.Entities:
Keywords: Adalimumab; Apremilast; Brodalumab; Guselkumab; Ixekizumab; Secukinumab
Year: 2020 PMID: 32656230 PMCID: PMC7325203 DOI: 10.1159/000507298
Source DB: PubMed Journal: Skin Appendage Disord ISSN: 2296-9160